Showing results (91-100 of 173) with videos related to

Sort By:
Pageof 18
American Journal of Hematology|May 13, 2022
Outcomes following venetoclax-based treatment in therapy-related myeloid neoplasmsMithun Vinod Shah, Rakchha Chhetri, Ruchita Dholakia, et al.
Blood Advances|April 2, 2024
The impact of cytotoxic therapy on the risk of progression and death in clonal cytopenia(s) of undetermined significanceMarissa Li, Anmol Baranwal, Mark Gurney, et al.
International Journal of Critical Illness and Injury Science|May 8, 2024
Metformin toxicity in the intensive care unit: A case series and review of the literatureKatherine Nicole Peake, Steven Tessier, Santo Longo, et al.
Mayo Clinic Proceedings|November 8, 2015
Primary Myelodysplastic Syndromes: The Mayo Clinic Experience With 1000 PatientsNaseema Gangat, Mrinal M Patnaik, Kebede Begna, et al.
Blood Cancer Journal|July 8, 2022
Therapy-related clonal cytopenia as a precursor to therapy-related myeloid neoplasmsMithun Vinod Shah, Abhishek A Mangaonkar, Kebede H Begna, et al.
British Journal of Haematology|February 4, 2024
Cardiac events in newly diagnosed acute myeloid leukaemia during treatment with venetoclax + hypomethylating agentsIsla M Johnson, Omer Karrar, Masooma Rana, et al.
American Journal of Hematology|April 12, 2021
Venetoclax with azacitidine or decitabine in blast-phase myeloproliferative neoplasm: A multicenter series of 32 consecutive casesNaseema Gangat, Paola Guglielmelli, Natasha Szuber, et al.
Cancer Medicine|November 14, 2023
A phase 2 and pharmacological study of sapanisertib in patients with relapsed and/or refractory acute lymphoblastic leukemiaAref Al-Kali, Ibrahim Aldoss, Pamela J Atherton, et al.
Blood Cancer Journal|September 22, 2023
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneityTalha Badar, Yenny A Moreno Vanegas, Ahmad Nanaa, et al.
British Journal of Haematology|March 5, 2025
Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndromeYael Kusne, Talha Badar, Terra Lasho, et al.
Pageof 18